Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Patisiran-LNP Pregnancy Surveillance Program

NCT05040373 is registered in ClinicalTrials.gov with Alnylam Pharmaceuticals as lead sponsor.

NCT NCT05040373
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05040373 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Patisiran-LNP Pregnancy Surveillance Program
Lead sponsor
Alnylam Pharmaceuticals
Phase
Observational
Overall status
Recruiting
Start date
August 1, 2020
Completion date
October 12, 2030
Enrollment
10 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

hereditary transthyretin-mediated (hattr) amyloidosis, polyneuropathy